病毒学报

参考文献

[1]田亚宾,张春涛.人乳头状瘤病毒核酸分型检测试剂的研究进展[J].中华肿瘤杂志,2018,40(10):729-735.

[2]De SanjoséS,Brotons M,Pavon M.The natural history of human papillomavirus infection[J].J Best Pract Res Clin Obstet Gynaecol,2018,47:2-13.

[3]So K A,Lee I H,Lee K H,Hong S R,Kim T J.Human papillomavirus genotype-specific risk in cervical carcinogenesis[J/OL].J Gynecol Oncol,2019,30(4):e52.DOI:10.3802/jgo.2019.30.e52

[4]Gupta S M,Mania-Pramanik J.Molecular mechanisms in progression of HPV-associated cervical carcinogenesis[J].J Biomed Sci,2019,26(1):28.DOI:10.1186/s12929-019-0520-2

[5]McClung N M,Gargano J W,Park I U,Whitney E,Dahl R M.Estimated number of cases of high-grade cervical lesions diagnosed among women-United States,2008 and 2016[J].Morb Mortal Wkly Rep,2019,68(15):337-343.

[6]Liontos M,Kyriazoglou A,Dimitriadis I,Dimopoulos M,Bamias.Systemic therapy in cervical cancer:30years in review[J].Crit Rev Oncol Hematol,2019,137:9-17.

[7]曹泽毅.子宫颈癌治疗的变迁和思考[J].中华妇产科杂志,2004,39(3):212-215.

[8]Wiik J,Sengpiel V,Kyrgiou M,Nilsson S,Mitra A,Tanbo T,Jonassen C M,Tannaes T,Sjoborg K D.Cervical microbiota in women with cervical intraepithelial neoplasia,prior to and after local excisional treatment,a Norwegian cohort study[J].BMC Womens Health,2019,19(1):30.DOI:10.1186/s12905-019-0727-0

[9]郑顺杰,胡旻,邵明君,胡美旭,杨英,张琳.LEEP联合重组人干扰素对进展期宫颈癌HPV感染患者SCCAg与CYFRA21-1水平的影响[J].中华医院感染学杂志,2018,28(24):141-144.

[10]Kyrgiou M,Athanasiou A,Paraskevaidi M,Mitra A,Kalliala I,Martinhirsch P,Arbyn M,Bennett P,Paraskevaidis E.Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth:systematic review and meta-analysis[J].BMJ,2016,354:i3633.DOI:10.1136/bmj.i3633

[11]Maina G,Ribaldone R,Danese S,Lombardo V,Cavagnetto C,Plazzotta C,Surico D.Obstetric outcomes in patients who have undergone excisional treatment for high-grade cervical squamous intraepithelial neoplasia[J].Eur J Obstet Gynecol Reprod Biol,2019,236:210-213.

[12]Frega A,Santomauro M,Sesti F,Di Giuseppe J,Colombrino C,Marziani R,Catalano A,Pavone M,Leone C,Mallozzi M.Preterm birth after loop electrosurgical excision procedure (LEEP):how cone features and microbiota could influence the pregnancy outcome[J].Eur Rev Med Pharmacol,2018,22(20):7039-7044.

[13]高楠,最新临床妇产科诊疗技术.天津：天津科技翻译出版有限公司,2012.

[14]刘语.宫颈冷刀锥切术和全子宫切除术对CINⅢ合并高危型HPV阳性患者治疗结局的影响[J].实用妇科内分泌杂志,2017,4(30):79-81.

[15]吴小肄,王维贵,郑颖馨,朱静.Analysis of diagnosis and treatment for cervical cancer of stageⅠA[J].复旦学报,2018,45(3):330-335.

[16]原昕,孟凡东.腹腔镜下广泛性子宫切除术治疗子宫颈鳞状细胞癌的临床疗效[J].中国医科大学学报,2019,48(1):54-58.

[17]谭青青,许培箴,朱鹏峰.腹腔镜下广泛性宫旁切除术加阴道上段切除术治疗子宫全切术后宫颈癌临床分析[J].中国实用妇科与产科杂志,2018,34(3):324-327.

[18]林芳,邹小平.社区开展预防肿瘤健康教育的效果评价[J].中国卫生事业管理,2010,27(8):517-518.

[19]Malanga G A,Yan N,Stark J.Mechanisms and efficacy of heat and cold therapies for musculoskeletal injury[J].Postgrad Med.,2015,127(1):57-65.

[20]张新华.实用肝胆胰恶性肿瘤学.武汉：武汉大学出版社,2012.

[21]Huang C,Zhuang W,Feng H,Guo H,Huang Y.Analysis of therapeutic effectiveness and prognostic factor on argon-helium cryoablation combined with transcatheter arterial chemoembolization for the treatment of advanced hepatocellular carcinoma[J].JCancer Res Ther,2016,12(7):148.

[22]Basu,Partha,Taghavi,Katayoun,Hu,Shang-Ying,Mogri,Sushma,Joshi,Smita.Management of cervical premalignant lesions[J].Curr Probl Cancer,2018,42(2):129-136.

[23]Mahira J,Elmir J,Mirsada M,Azra H.Difference between cryotherapy and follow up low grade squamous lesion of cervix uteri[J].Med Arch,2017,71(4):280-283.

[24]Campbell C,Kafwafwa S,Brown H,Walker G,Madetsa B,Deeny M,Kabota B,Morton D,Ter Haar R,Grant L.Use of thermo-coagulation as an alternative treatment modality in a'screen-and-treat'programme of cervical screening in rural Malawi[J].Int J Cancer,2016,139(4):908-915.

[25]Garaix F,Hery G,Tsimaratos M,Colson P,Tamalet C.Human papillomavirus type 7-associated anal condyloma after renal transplantation in a child[J/OL].Pediatr Transplant,2019,23(5):e13470.

[26]Naud P S V,Muwonge R,Passos E P,Magno V,Matos J,Sankaranarayanan R.Efficacy,safety,and acceptability of thermocoagulation for treatment of cervical intraepithelial neoplasia in a hospital setting in Brazil[J].Int J Gynaecol Obstet,2016,133(3):351-354.

[27]Bristow I,Wen C L,Lee A,Holbrook D,ArdernJones M R.Microwave therapy for cutaneous human papilloma virus infection[J].Eur J Dermatol,2017,27(5):511-518.

[28]Chen X,Tan L,Liu T,Meng X.Micro-nanomaterials for tumor microwave hyperthermia:Design,preparation,and application[J].Curr Drug Deliv,2017,14(3):307-322.

[29]王紫涵,张玉杰,高昱,张诚,田兰馨.生殖器高危HPV感染及防治现状[J].中国艾滋病性病,2019,25(2):213-216.

[30]Wu Y,Song G,Li M,Lun W.Condyloma acuminata on the nipple and coronary sulcus of the penis:A case report[J/OL].Medicine(Baltimore),2019,98(16):e15109.

[31]Navarro Santana B,Sanz Baro R,Orozco R,Plaza Arranz J.Cervical vaporization in LSIL and persistent HPV infection[J].Taiwan J Obstet Gynecol,2018,57(4):475-478.

[32]Mariya T,Nishikawa A,Sogawa K,Suzuki R,Saito M,Kawamata A,Shimizu A,Nihei T,Sonoda T,Saito T.Virological and cytological clearance in laser vaporization and conization for cervical intra-epithelial neoplasia grade 3[J].J Obstet Gynaecol Res,2016,42(12):1808-1813.

[33]Zhang W,Zhang A,Sun W,Ying Y,Hong L.Efficacy and safety of photodynamic therapy for cervical intraepithelial neoplasia and human papilloma virus infection[J/OL].Medicine,2018,97(21):e10864.

[34]El-Daly S M,Abba M L,Gamal-Eldeen A M.The role of microRNAs in photodynamic therapy of cancer[J].Eur J Med Chem,2017,142:550-555.

[35]王爱玲,翟晓玲.宫颈上皮内瘤变Ⅲ级患者宫颈锥切术后人乳头瘤病毒感染的诊断及治疗[J].中国老年学杂志,2019(38):124-126.

[36]王钊.槲皮素和茶多酚对光动力疗法损伤PC12细胞效应的影响[J].中国药理学通报,34(10):1392-1396.

[37]Maldonado Alvarado E,Osorio Peralta M O,Moreno Vázquez A,Ramón Gallegos E.Effectiveness of photodynamic therapy in elimination of HPV-16 and HPV-18 associated with CIN I in Mexican women[J].Photochem Photobiol,2017,93(5):1269-1275.

[38]朱梦琪,史澍睿,万国运,王银松,王悦,张连云,赵艳红.5-氨基酮戊酸介导的光动力治疗对口腔鳞状细胞癌体内外作用的研究[J].中华口腔医学杂志,2019,54(3):176-182.

[39]王莉.5-氨基酮戊酸光动力疗法在治疗HPV相关性感染中的安全性及有效性的体外实验研究[D].南方医科大学,2019.

[40]牟燕,刘晓芳,许温馨,何泉江,何玉春,何佳.聚焦超声对宫颈持续高危型HPV感染治疗的疗效研[J].重庆医学,2019,48(2):281-284.

[41]林琳,傅亚均.宫颈上皮内瘤变Ⅰ级合并高危型HPV感染行宫颈环形电切术与聚焦超声治疗的疗效对比[J].传染病信息,2018,31(4):368-371.

[42]朱丽娟,周树林,江希萍.重组人干扰素α2b联合洁悠神对宫颈持续HPV感染患者端粒酶与HPV16/18 E6蛋白表达的影响[J].中国现代医学杂志,2017(25):29-33.

[43]Van Seters M,Van Beurden M,Ten Kate F J W,Beckmann I,Ewing P C,Eijkemans M J C,Kagie MJ,Meijer C J M,Aaronson N K,Kleinjan A.Treatment of vulvar intraepithelial neoplasia with topical imiquimod[J].N Engl J Med,2008,358(14):1465-1473.

[44]van de Sande AJM,Koeneman MM,Gerestein CG,van Beekhuizen HJ.TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia(TOPIC-2 trial):a study protocol for a randomized controlled trial[J].2018,18(1):655.

[45]Koeneman M M,Essers B A,Gerestein C G,Dirksen C D.Treatment of cervical intraepithelial neoplasia:Patients preferences for surgery or immunotherapy with imiquimod[J].J Immunother,2017,40(4):148-153.

[46]Rahangdale L,Lippmann Q K,Garcia K,Budwit D,Le L V.Topical 5-fluorouracil for treatment of cervical intraepithelial neoplasia 2:A randomized controlled trial[J/OL].Am J Obstet Gynecol,2013,210(4):314.e311-314.e318.

[47]Pachterbeke C V,Bucella D,Rozenberg S,Manigart Y,Gilles C,Larsimont D,Houte K V,Reynders M,Snoeck R,Bossens M.Topical treatment of CIN 2+by cidofovir:Results of a phase II,double-blind,prospective,placebo-controlled study[J].Gynecol Oncol,2009,115(1):69-74.

[48]孙红,朱勤贤,顾伯林.益气除湿解毒汤治疗宫颈HPV感染的临床研究[J].南京中医药大学学报,2017,33(3):232-234.

[49]孙桂霞,李艳云,杨少琴.化湿解毒汤对高级别CIN高危型HPV感染者LEEP术后湿热下注证患者转归的影响[J].中国实验方剂学杂志,2017,23(16):190-195.

[50]赵健,廖秦平,谢红.保妇康栓治疗人乳头瘤病毒感染的临床观察[J].实用妇产科杂志,2015(1):45-48.

[51]刘嵘,祝达,李天,濮德敏,邹云楠,杜娟,袁永群.二黄栓治疗高危型HPV持续阳性宫颈病变的临床疗效观察及机制探讨[J].华中科技大学学报,2018,47(3):325-328.

[52]徐垲,薛晓鸥,马秀丽,秦蕾.紫柏凝胶外治方治疗宫颈高危型人乳头瘤病毒感染的临床观察[J].北京中医药大学学报,2015,38(8):566-568.

[53]王艳,何丽清,蔡序子,王雪峰.派特灵治疗高危人乳头瘤病毒持续感染患者的疗效及安全性研究[J].中国全科医学,2019,22(11):1323-1327.

[54]冯凌,宋志琴,邵玉琳,陈君,谭洁.派特灵用于宫颈高危型人乳头瘤病毒感染清除的临床观察[J].中国妇产科临床杂志,2017(4):76-77.

[55]冉雪梦,王伟,王世欣,薛辉.清热解毒方治疗宫颈高危型人乳头瘤病毒感染的临床研究[J].中国中西医结合杂志,2018,38(4):421-424.

[56]周利军,李雯,刘君娟.宫颈癌免疫治疗与应用展望[J].现代妇产科进展,2018,27(9):709-712.

[57]王致萍,柳欣林,王大宁,夏宁邵,李少伟.人乳头瘤病毒致癌蛋白E6的结构与功能研究进展[J].病毒学报,2019,35(2):292-299.DOI:10.13242/j.cnki.bingduxuebao.003507

[58]Komatsu A,Igimi S,Kawana K.Optimization of human papillomavirus (HPV) type 16 E7-expressing lactobacillus-based vaccine for induction of mucosal E7-specific IFNγ-producing cells[J].Vaccine,2018,36(24):3423-3426.

[59]Garza-Morales R,Perez-Trujillo J J,Martinez-Jaramillo E,Saucedo-Cardenas O,Loera-Arias M,Garcia-Garcia A,Rodriguez-Rocha H,Yolcu E,Shirwan H,GomezGutierrez J.A DNA vaccine encoding SA-4-1BBL fused to HPV-16 E7 antigen has prophylactic and therapeutic efficacy in a cervical cancer mouse model[J].Cancers(Basel),2019,11 (1):96.doi:10.3390/cancers11010096

[60]Yang Y,Che Y,Zhao Y,Wang X.Prevention and treatment of cervical cancer by a single administration of human papillomavirus peptide vaccine with CpGoligodeoxynucleotides as an adjuvant in vivo[J].Int Immunopharmacol,2019,69:279-288.

[61]Da Silva D M,Skeate J G,Chavez-Juan E,Lühen KP,Wu J M,Wu C M,Kast W M,Hwang K.Therapeutic efficacy of a human papillomavirus type 16E7 bacterial exotoxin fusion protein adjuvanted with CpG or GPI-0100 in a preclinical mouse model for HPV-associated disease[J].Vaccine,2019,37(22):2915-2924.

[62]王卡娜,郄明蓉.HPV治疗性疫苗研究现状[J].实用妇产科杂志,2017,33(2):89-91.

[63]Meng X,Shi X,Li Y,Luan H,Liu W.LEEP/Cone combined with photodynamic therapy for successful treatment of high-grade squamous intraepithelial lesion[J].Photodiagnosis Photodyn Ther,2019,25:237-238.

[64]夏丹丹,席晓薇.IL-15联合HPV基因疫苗治疗宫颈癌的前景[J].南京医科大学学报：自然科学版,2019,39(3):436-441.